InvestorsHub Logo
Followers 1330
Posts 250339
Boards Moderated 52
Alias Born 12/07/2009

Re: None

Thursday, 05/12/2022 10:41:38 AM

Thursday, May 12, 2022 10:41:38 AM

Post# of 38105
$AVCO NEWS as The new CAR-NK therapies in development are intended to build upon and complement AVA-011, Avalon's lead CAR-T candidate.

https://finance.yahoo.com/news/avalon-globocare-adds-car-nk-165721173.html


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.